thoracic surgery News
-
ESTS 2020 VC welcomes you
Join us for the most prominent annual online activity #ests2020vc in Thoracic Surgery. We are proud that Reach Surgical’s Endo III stapler and various reload selections play a vital role in helping thoracic surgeons around the world. Enjoy a special video performance of single-port video-assisted thoracoscopic lung segmentectomy by Professor Yuming Zhu and many others at the virtual ...
-
Johnson & Johnson Institutes launches COVID-19 Community Hub
AIS with collaboration with Johnson & Johnson Institute has launched a special website dedicated to internal and external content to help healthcare workers keep up on the latest news on COVID-19. The site features: Webinars presented by physicians and leaders in the battle against COVID-19 The New Normal in Elective Surgery Thoracic Surgery on the Frontline of COVID-19 Managing ...
-
Preclinical results of AdjuCor’s technology to be presented at the upcoming 101st annual meeting of the American Association for Thoracic Surgery (AATS)
In another great achievement for AdjuCor’s ground-breaking new technology within a short period of time, its submitted abstract has been accepted for presentation at the prestigious 101st American Association for Thoracic Surgery (#AATS2021). Prof. Stephan Schueler will be presenting specifics relating to the augmentation technology. Professor Stephan Schueler, Head of Mechanical ...
By AdjuCor GmbH
-
World`s First Use of Lightpoint Medical`s Robotic Gamma Probe in Lung Surgery Performed in the U.S.
Lightpoint Medical today announced that Dr. Doug Adams, a specialist in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio) performed a first-in-the-world lung procedure with SENSEI, the company's new miniature robotic gamma probe. SENSEI is smaller than an AA battery and designed specifically for robotic and minimally-invasive surgery. The miniature size and ...
-
CONMED Completes Acquisition of Biorez, Inc.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. Biorez is a medical device start-up based in New Haven, CT and is focused on advancing the healing of soft tissue using its proprietary BioBrace® Implant technology. The BioBrace Implant is an innovative bioinductive ...
By Biorez Inc.
-
Versius has indication extended into thoracic surgery
CMR Surgical (CMR) today announced the Versius Surgical Robotic System® has been indicated for thoracics to support surgeons providing minimally invasive surgery to patients undergoing operations in the lungs, thymus and oesophagus. Following a gradual introduction with specific case and procedure selection, Versius has now been used in both major and minor cases including oesophagomyotomies, ...
-
Versius surgical robot used for first time in an Italian public hospital
CMR Surgical (CMR) – a global surgical robotics business – today announced the introduction of the Versius® Surgical Robotic System, at Policlinico di Milano, a leading research hospital and care institute (IRCCS), and one of the largest healthcare facilities in Lombardy, Italy. Within the hospital, Versius will be used in a multi-specialty robotics programme including thoracic ...
-
Versius launched in Poland as CMR expands presence across region
CMR Surgical – the global surgical robotics business – has today announced the introduction of the Versius® Surgical Robotic System in Poland at Salve Medica Medical Centre in Lódz, the third largest city in Poland. At Salve Medica, Versius is being used in urology, with plans to expand into general surgery and gynaecology as part of a multispecialty robotics programme. ...
-
Versius introduced in leading public hospitals in Egypt
CMR Surgical – the global surgical robotics business – has today announced the launch of its Versius® Surgical Robotic System in Egypt. Versius has been introduced at both Ain Shams University Specialized Hospital and the International Hospital for Urology & Nephrology (IHUN), as CMR works with ATG group to meet significant demand for Versius from one of the largest countries ...
-
First Patients Treated in First-in-Human Trial for ACTISEAL – Polyganics’ Innovative Liver and Pancreas Sealant Patch
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, today announced treatment of the first patients in its first-in-human study for ACTISEAL®, its Liver and Pancreas Sealant Patch. The ‘SHIELDS’ trial is a prospective, multicenter study, evaluating the safety and performance of ACTISEAL® in reducing fluid ...
-
CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device
CorWave announced that it successfully completed its first 60-day preclinical study to evaluate its Left Ventricular Assist Device (LVAD). The results were presented at the 46th Annual Conference of the European Society for Artificial Organs (ESAO) in Hannover. Trevor Snyder, PhD, Senior Director, Translational and Clinical Research at CorWave, delivered an oral presentation, “CorWave ...
By CorWave
-
CARMAT announces the second center implanting its total artificial heart in the United States
The implant was performed at UofL Health – Jewish Hospital by University of Louisville physicians within the framework of the U.S. Early Feasibility Study. CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage ...
By Carmat
-
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert™ contrast minimization devices, complemented by GE Healthcare's range of iodinated x-ray contrast media, offer healthcare ...
-
BioStable Surpasses 500 Patients Treated Worldwide with the HAART Devices
BioStable Science & Engineering, Inc., a medical technology company focused on products for aortic valve repair for the treatment of aortic insufficiency, today announced that over 500 patients worldwide have now been treated using the HAART Aortic Annuloplasty Device. “Many cardiothoracic surgeons recognize that the young aortic insufficiency patient population cannot be treated with ...
-
Endospan Enters Into Strategic Distribution Agreement With CryoLife
Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease, today announced it has entered into strategic distribution and credit facility agreements with CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease. Under the terms of the agreement, CryoLife will have exclusive European distribution rights to NEXUS™, the first ...
-
BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices
BioStable Science & Engineering, Inc., (“BioStable”) announced today the company has received CE Mark approval for the HAART 200 Aortic Annuloplasty Device for use during bicuspid aortic valve repair. With CE Mark approval of both the HAART 300 and HAART 200 Aortic Annuloplasty Devices, BioStable will be able to offer surgeons within the European Union a comprehensive portfolio of ...
-
CONMED Announces Definitive Agreement to Acquire Biorez, Inc.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be ...
By Biorez Inc.
-
CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as Vice President, Medical Affairs Cardiovascular
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Professor Daniel Wendt, MD, PhD, MHBA, FETCS as Vice President, Medical Affairs Cardiovascular commencing January 1, 2022. Dr. Wendt is an internationally renowned academic cardiac surgeon with over ...
-
Porsche cars North America and Porsche AG of Stuttgart, Germany to support the quail porsche race car classic
Bonnie Addario of The Bonnie J. Addario Lung Cancer Foundation and Dr. David Jablons, Director of the UCSF Thoracic Oncology Program are honored to announce today that Porsche will be a major collaborator in the October 16, 2011 exclusive QUAIL PORSCHE RACE CAR CLASSIC in Carmel, California at the famed Quail Lodge and Golf Club. This once-in-a-lifetime gathering of vintage Porsche race cars from ...
-
Biostage Hires David Green as Chief Executive Officer
Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company with successful "first-in-human" experience in esophageal cancer and FDA approval to commence a clinical trial of its Biostage Esophageal Implant for esophageal disease, today announced it has hired David Green as its Chief Executive Officer and appointed Mr. Green as Chairman of the Board of Directors (the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you